126 related articles for article (PubMed ID: 21641951)
21. Progress toward poliomyelitis eradication--India, January 2007-May 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(26):719-23. PubMed ID: 19590492
[TBL] [Abstract][Full Text] [Related]
22. Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial.
Snider CJ; Zaman K; Wilkinson AL; Binte Aziz A; Yunus M; Haque W; Jones KAV; Wei L; Estivariz CF; Konopka-Anstadt JL; Mainou BA; Patel JC; Lickness JS; Pallansch MA; Wassilak SGF; Steven Oberste M; Anand A
Vaccine; 2023 Sep; 41(41):6083-6092. PubMed ID: 37652822
[TBL] [Abstract][Full Text] [Related]
23. Monovalent polio immunisation--a strategy for India.
Chatterjee A; Chawla A
J Indian Med Assoc; 2005 Dec; 103(12):682-5. PubMed ID: 16821665
[TBL] [Abstract][Full Text] [Related]
24. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
25. OPV cannot eradicate polio from India: do we need any further evidence?
Paul Y
Vaccine; 2008 Apr; 26(17):2058-61. PubMed ID: 18378367
[TBL] [Abstract][Full Text] [Related]
26. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.
Steele AD; De Vos B; Tumbo J; Reynders J; Scholtz F; Bos P; de Beer MC; Van der Merwe CF; Delem A
Vaccine; 2010 Sep; 28(39):6542-8. PubMed ID: 18786585
[TBL] [Abstract][Full Text] [Related]
27. The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India.
Mohanty L; John TJ; Pawar SD; Ramanan PV; Agarkhedkar S; Haldar P
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675806
[TBL] [Abstract][Full Text] [Related]
28. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
Xu A
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
[TBL] [Abstract][Full Text] [Related]
29. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
[TBL] [Abstract][Full Text] [Related]
30. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
Cáceres VM; Sutter RW
Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
[TBL] [Abstract][Full Text] [Related]
31. Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern India.
Bahl S; Estívariz CF; Sutter RW; Sarkar BK; Verma H; Jain V; Agrawal A; Rathee M; Shukla H; Pathyarch SK; Sethi R; Wannemuehler KA; Jafari H; Deshpande JM
J Infect Dis; 2014 Nov; 210 Suppl 1():S243-51. PubMed ID: 25316842
[TBL] [Abstract][Full Text] [Related]
32. Immunization in India with trivalent and monovalent oral poliovirus vaccines of enhanced potency.
John TJ; Devarajan LV; Balasubramanyan A
Bull World Health Organ; 1976; 54(1):115-7. PubMed ID: 1087587
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.
Steele AD; Reynders J; Scholtz F; Bos P; de Beer MC; Tumbo J; Van der Merwe CF; Delem A; De Vos B
J Infect Dis; 2010 Sep; 202 Suppl():S93-100. PubMed ID: 20684724
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
[TBL] [Abstract][Full Text] [Related]
35. Antibody response to three doses of standard and double dose of trivalent oral polio vaccine.
Agarwal A; Sharma D; Kumari S; Khare S
Indian Pediatr; 1991 Oct; 28(10):1141-5. PubMed ID: 1665840
[TBL] [Abstract][Full Text] [Related]
36. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.
Grassly NC; Wenger J; Durrani S; Bahl S; Deshpande JM; Sutter RW; Heymann DL; Aylward RB
Lancet; 2007 Apr; 369(9570):1356-1362. PubMed ID: 17448821
[TBL] [Abstract][Full Text] [Related]
37. Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: a randomized controlled trial.
Habib MA; Soofi S; Sheraz A; Bhatti ZS; Okayasu H; Zaidi SZ; Molodecky NA; Pallansch MA; Sutter RW; Bhutta ZA
Vaccine; 2015 Feb; 33(6):819-25. PubMed ID: 25500307
[TBL] [Abstract][Full Text] [Related]
38. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
[TBL] [Abstract][Full Text] [Related]
39. Policy. OPV cessation--the final step to a "polio-free" world.
Aylward RB; Sutter RW; Heymann DL
Science; 2005 Oct; 310(5748):625-6. PubMed ID: 16254173
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of three doses of oral polio immunization beginning within the first four days of life.
Bhatawdekar AM; Kumta NB; Dave KH; Bharucha BA
Indian Pediatr; 1990 Sep; 27(9):911-4. PubMed ID: 2286433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
